Skip to main content
. 2018 Dec 4;3(1):147–159. doi: 10.1002/hep4.1274

Figure 6.

Figure 6

TC treatment enhances canalicular and basolateral BA transporters. (A) Fecal BA excretion (n = 4) and urinary BA concentration (n = 3) in TC‐treated (1 week) DKO and BKO. (B) mRNA levels of BA transporters (n = 4). (C) Immunostaining of ABCB11, ABCC3, and ABCC4 (magnification ×200). Arrowhead, positive area. Student t test; *P < 0.05, ***P < 0.005 compared to CO‐treated group. Abbreviation: MDR, multidrug resistance.